Previous studies in humans and animal models have shown that the 5-LOX/LT pathway and, more recently, the 12/15-lipoxygenase pathway are linked to the pathogenesis of obesity and its associated metabolic disorders [38,39], as well as to insulin resistance and fatty liver disease [40,41,42]. Here, ALOX5 is linked to metabolic disease.